ZA202401941B - Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants - Google Patents

Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants

Info

Publication number
ZA202401941B
ZA202401941B ZA2024/01941A ZA202401941A ZA202401941B ZA 202401941 B ZA202401941 B ZA 202401941B ZA 2024/01941 A ZA2024/01941 A ZA 2024/01941A ZA 202401941 A ZA202401941 A ZA 202401941A ZA 202401941 B ZA202401941 B ZA 202401941B
Authority
ZA
South Africa
Prior art keywords
fucan
transplants
treatment
compositions
capsular contracture
Prior art date
Application number
ZA2024/01941A
Other languages
English (en)
Inventor
Sun Hesong
Millet Ian
Michael Kevin Springate Christopher
Original Assignee
Arc Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arc Medical Inc filed Critical Arc Medical Inc
Publication of ZA202401941B publication Critical patent/ZA202401941B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
ZA2024/01941A 2021-08-20 2024-03-07 Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants ZA202401941B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163235316P 2021-08-20 2021-08-20
US202263354322P 2022-06-22 2022-06-22
PCT/CA2022/051254 WO2023019360A1 (en) 2021-08-20 2022-08-18 Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants

Publications (1)

Publication Number Publication Date
ZA202401941B true ZA202401941B (en) 2025-06-25

Family

ID=85239322

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2024/01941A ZA202401941B (en) 2021-08-20 2024-03-07 Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants

Country Status (10)

Country Link
US (1) US20240350531A1 (https=)
EP (1) EP4387630A4 (https=)
JP (1) JP2024532867A (https=)
KR (1) KR20240087708A (https=)
AU (1) AU2022328865A1 (https=)
CA (1) CA3229366A1 (https=)
IL (1) IL310940A (https=)
MX (1) MX2024002190A (https=)
WO (1) WO2023019360A1 (https=)
ZA (1) ZA202401941B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102024104757B4 (de) * 2024-02-21 2026-03-26 Acandis Gmbh Medizinische Vorrichtung mit verbesserter antithrombotischer Wirkung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933290B2 (en) * 2007-06-26 2015-01-13 Sofradim Production Sas Mesh implant
WO2019210414A1 (en) * 2018-05-02 2019-11-07 Arc Medical Devices Inc. Fucan-based compounds and complexes
US11446326B2 (en) * 2018-07-27 2022-09-20 ARC Medical Devices Highly sulfated fucans for the treatment of fibrous adhesions

Also Published As

Publication number Publication date
MX2024002190A (es) 2024-06-24
WO2023019360A1 (en) 2023-02-23
US20240350531A1 (en) 2024-10-24
EP4387630A4 (en) 2025-07-30
IL310940A (en) 2024-04-01
JP2024532867A (ja) 2024-09-10
EP4387630A1 (en) 2024-06-26
KR20240087708A (ko) 2024-06-19
AU2022328865A1 (en) 2024-03-14
CA3229366A1 (en) 2023-02-23

Similar Documents

Publication Publication Date Title
He et al. Review on magnesium and magnesium-based alloys as biomaterials for bone immobilization
Campoccia et al. A review of the clinical implications of anti-infective biomaterials and infection-resistant surfaces
KR101578591B1 (ko) 간엽줄기세포 및 면역조절 t 세포를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
CA2656523A1 (en) Flexible bioresorbable hemostatic packing and stent
WO2011026614A3 (en) Compositions and methods for disinfecting materials
WO2012071526A3 (en) Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
MX2009001323A (es) Aposito solido para tratar tejido herido.
ZA202401941B (en) Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants
MX2022009435A (es) Composiciones y metodos para el tratamiento de enfermedades oculares.
WO2012023510A1 (ja) 生体インプラント
WO2017043953A3 (es) Proceso de obtención de un compuesto de aspersión de células endoteliales microvasculares de piel y células madre mesenquimales y su método de aplicación para la regeneración tisular
MX2024004722A (es) Compuestos y sus usos como inhibidores de gpr183.
CA3260661A1 (en) Sterile human placental allografts and their manufacturing processes
MX2024006746A (es) Métodos de uso de agentes de interleucina-2.
MX2024006374A (es) Composiciones y metodos de bioproteccion basados en microalgas para plantas hospederas.
WO2022204722A3 (en) Controlled release of bacteriophage to treat implant infections
WO2019132604A3 (ko) 인간 섬유연골 또는 탄성연골 재생용 조성물
WO2024151852A3 (en) Devices and methods of a medicament-producing implantable matrix
SA522431729B1 (ar) مركبات وطرق لعلاج أمراض متعلقة بالأوكسالات.
CN104645422B (zh) 一种具有强烈抗菌功能的生物可降解镁合金
Vallet-Regí et al. New materials and complications of prostheses in humans: situation in Spain
MX2022015060A (es) Composición que comprende oligosacárido de glucosa y proceso para elaborar la misma y usarla.
EA200701598A1 (ru) Способ и композиция для восстановления эпителиальных и других клеток и тканей
Yu et al. Antibacterial Activity of a Novel Titanium–Copper (Ti–Cu) Sintered Alloy in Preventing Periprosthetic Joint Infection in Rabbit Model
CN103734124B (zh) 一种骨科移植材料的保存方法